Natural product therapy for Bone disorders: Chebulagic acid (CHA), isolated from Terminalia chebula, inhibits the expression of Tgif2 and suppresses osteoporosis and bone metastasis via up-regulation of its target gene, 3/December/2016, 7.49 pm

Natural product Life-extension therapy: EHHM (E‑[6′-(5′-hydroxypentyl)tricosyl]-4-hydroxy-3-methoxycinnamate), found in Livistona Chinensis, inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span, 3/December/2016, 5.57 pm
December 3, 2016
Small molecule-based anti-ageing therapy: Yin Yang 1 (YY1) increases NMN levels, decreases age-associated weight gain, augments energy metabolism, improves physical activity and insulin sensitivity, promotes healthy lipid profile, and improves eye function via down regulation of its target gene, 3/December/2015, 8.01 am
December 3, 2016
Show all

Introduction: What they say

A study from the Department of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA has reported that “miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2.”

This study was published in the June 25, 2014 Nature  [I.F >42] by Prof. Wan Y, Krzeszinski and others from  the Department of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.


What we say:

On the foundation of this interesting finding, Dr L Boominathan, Director-cum-chief Scientist of GBMD, reports here that: Natural product therapy for Bone disorders: Chebulagic acid (CHA), isolated from Terminalia chebula, inhibits the expression of Tgif2 and suppresses osteoporosis and bone metastasis via up-regulation of its target gene.


From Research findings to Therapeutic utility

Chebulagic acid (CHA), by up-regulating its target gene, it may suppress the expression of Tgif2 (figs. 1-2). Thereby, it may inhibit the progression of Osteoporosis and bone metastasis. 

Terminalia chebula (Haritaki)

Figure 1. Terminalia chebula. Chebulagic acid, isolated from Terminalia chebula, inhibits the progression of Osteoporosis and bone metastasis via down regulation of Tgif2

 

Chebulagic acid க்கான பட முடிவு

Figure 2. Chebulagic acid. Image credit: Wikipedia

price-50[easy_payment currency=”USD”]

Thus, pharmacological formulations encompassing “Chebulagic acid (CHA) or its analogues or CHA plus any of the known compounds that are in use to treat osteoporosis” can be used to inhibit osteoporosis and bone metastasis.


Details of the research findings

Undisclosed information: How   Chebulagic acid  suppresses the expression of Tgif2

Amount: $50#

Idea Formulated (with experimental evidence) by: Dr L Boominathan PhD

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

#Research cooperation

For purchase & payment details, you may reach us at admin@genomediscovery.org


 Reference:

CitationBoominathan, L., Natural product therapy for Bone disorders: Chebulagic acid (CHA), isolated from Terminalia chebula, inhibits the expression of Tgif2 and suppresses osteoporosis and bone metastasis via up-regulation of its target gene, 3/December/2016, 7.49 pm., Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Web: http://genomediscovery.org or http://newbioideas.com

Comments are closed.